Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21(WAF1/CIP1) induction, G2/M arrest, and apoptosis

Journal of Cellular Biochemistry

Volumn 69, Issue 1, 1998, Pages 44-54

  Shao, Zhi Ming ^a   Alpaugh, Mary L ^a   Fontana, Joseph A ^b   Barsky, Sanford H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Breast cancer; G2 M arrest; Genistein; P21(WAF1 CIP1)

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GENISTEIN; MESSENGER RNA; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; G2 PHASE; GENE EXPRESSION; GENISTEIN; HUMANS; MITOSIS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032054451     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980401)69:1<44::AID-JCB5>3.0.CO;2-V     Document Type: Article

References (38)

1. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995): p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92:8493-8497.
2. Barnes S, Grubbes C, Setchell KDR, Carison J (1990): Soybeans inhibit mammary tumors in models of breast cancer. In Pariza MW, Aeschbacher H-U, Felton JS, Sato S (eds): "Mutagens and Carcinogens in the Diet." New York: Wiley-Liss.
3. Barnes S, Peterson TG (1995): Biochemical targets of the isoflavone genistein in tumor cell lines. Pro Soc Exp Bio Med 208:103-108.
4. Batto MB, Li P, Panus J F, Howe D J, Xiong Y, Wang X F (1995): Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549.
5. Constantinou A, Huberman E (1995): Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Pro Soc Exp Bio Med 125:109-115.
6. WAF1/CIP1 expression in normal and neoplastic tissue. Cancer Res 55:2910-2919.
7. Feinberg AP, Vogelstein B (1983): A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
8. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993): Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690-2694.
9. WAF1/CIP1 expression in human breast epithelial cells. Oncogene 11:253-261.
10. 1 cyclin-dependent kinases. Cell 75:805-816.
11. Hartwell L, Weinert TA (1989): Checkpoints. Controls that ensure the order of cell cycle events. Science (Washington, DC) 246:629-634.
12. Hyder SM, Chiappetta C, Murthy L, Stancel GM (1997): Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res 57:2547-2549.
13. 2 checkpoint response to ionizing radiation. Cancer Res 55:2500-2502.
14. Li X-S, Rishi AK, Shao Z-M, Dawson M I, Jong L, Shroot B, Reichert U, Ordonez J, Fontana JA (1996): Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res 56:5055-5062.
15. Li Y, Jenkins CW, Nichols MA, Xiong Y (1994): Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
16. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H., Aoike A (1993): Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331.
17. Messina M, Barnes S (1991): Workshop report from the division of Cancer Etiology, National Cancer Institute, NIH. The role of soy in reducing the risk of certain cancers. J J Natl Cancer Inst 83:541-546.
18. Messina MJ, Persky V, Setchell KDR, Barnes S (1994): Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 21:115-131.
19. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. (1994): Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395.
20. Niewolik D, Vojtesek B, Kovarik (1995): p53 derived from human tumor cell lines and containing distinct point mutations can be activated to bind to its consensus sequence. Oncogene 10:881-890.
21. cdk2 and its companion cyclin-dependent kinases. Trend Cell Biol 3:296-301.
22. O'Conner PM, Kohn KW (1992): A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells. Semin Cancer Biol 3:409-416.
23. Parker SL, Tong T, Bolden S, Wingo PA (1996): Cancer Statistics. CA Cancer Clin 65:5-27.
24. Peterson G (1995): Evaluaion of the biochemical targets of genistein in tumor cells. J Nutr 125 (Suppl):784s-789s.
25. Peterson G, Barnes S (1991): Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667.
26. Peterson G, Barnes S (1996): Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Diff 7:1345-1351.
27. Safarians S, Sternlicht MD, Yamanishi DT, Love SM, Barsky SH (1996): Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies. Cancer Res 56:3560-3569.
28. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504.
29. Shao Z-M, Sheikh M S, Rishi AK, Dawson M, Li X-S, Wilber, JF, Feng P, Fontana JA (1995): Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp Cell Res 218:1-8.
30. Sheikh M S, Li X-S, Chen JC, Shao Z-M, Ordonez JV, Fontana JA (1994): Mechanisms of regulation of WAF1/ CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathway. Oncogene 9:3407-3415.
31. WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11:1899-1905.
32. 1 cyclins. Cell 73:1059-1065.
33. 1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
34. Spinozzi F, Pagliacci C, Migliorati G, Moraca R, Grignani F, Riccardi C, Nicoletti I (1994): The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cell. Leukemia Res 18: 431-439.
35. Tchou WW, Rom WN, Tchou-Wong KM (1996): Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest. J Biol Chem 271:29556-29560.
36. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z (1992): Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemia MOLT-4 and HL-60 cells. Cancer Res 52:6200-6208.
37. Wang, TTY, Sathyamoorthy, Phang JM (1996): Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271-275.
38. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D (1993): p21 is a universal inhibitor of cyclin kinases. Nature (London) 366:701-704.